A Quebec court authorized Labopharm Inc (DDS.TO) to hold a special meeting of shareholders for the approval of the Canadian biotech firm's acquisition by Paladin Labs (PLB.TO). The meeting is due to be held on Oct. 5, and Labopharm needs the support of two-thirds of its shareholders, the company said on Monday.
Shares of DDS remained unchanged at $45.50. In the past year, the shares have traded as low as $20.76 and as high as $61.08. On average, 1336280 shares of DDS exchange hands on a given day and today's volume is recorded at 0.
Source
